129 related articles for article (PubMed ID: 16403974)
1. The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells.
Sunjic SB; Cipak A; Rabuzin F; Wildburger R; Zarkovic N
Biofactors; 2005; 24(1-4):141-8. PubMed ID: 16403974
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of Osteosarcoma Cells to Concentration-Dependent Bioactivities of Lipid Peroxidation Product 4-Hydroxynonenal Depend on Their Level of Differentiation.
Sunjic SB; Gasparovic AC; Jaganjac M; Rechberger G; Meinitzer A; Grune T; Kohlwein SD; Mihaljevic B; Zarkovic N
Cells; 2021 Jan; 10(2):. PubMed ID: 33572933
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells.
Borovic S; Cipak A; Meinitzer A; Kejla Z; Perovic D; Waeg G; Zarkovic N
Redox Rep; 2007; 12(1):50-4. PubMed ID: 17263909
[TBL] [Abstract][Full Text] [Related]
4. Induction of differentiation in human HL-60 cells by 4-hydroxynonenal, a product of lipid peroxidation.
Barrera G; Di Mauro C; Muraca R; Ferrero D; Cavalli G; Fazio VM; Paradisi L; Dianzani MU
Exp Cell Res; 1991 Dec; 197(2):148-52. PubMed ID: 1959552
[TBL] [Abstract][Full Text] [Related]
5. 4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity.
Pizzimenti S; Menegatti E; Berardi D; Toaldo C; Pettazzoni P; Minelli R; Giglioni B; Cerbone A; Dianzani MU; Ferretti C; Barrera G
J Nutr Biochem; 2010 Sep; 21(9):818-26. PubMed ID: 19733043
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships for growth inhibition and induction of apoptosis by 4-hydroxy-2-nonenal in raw 264.7 cells.
Haynes RL; Szweda L; Pickin K; Welker ME; Townsend AJ
Mol Pharmacol; 2000 Oct; 58(4):788-94. PubMed ID: 10999949
[TBL] [Abstract][Full Text] [Related]
7. 4-Hydroxy-2-nonenal induces apoptosis by inhibiting AKT signaling in human osteosarcoma cells.
Ji GR; Yu NC; Xue X; Li ZG
ScientificWorldJournal; 2014; 2014():873525. PubMed ID: 24711740
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in RAW 264.7 cells exposed to 4-hydroxy-2-nonenal: dependence on cytochrome C release but not p53 accumulation.
Haynes RL; Brune B; Townsend AJ
Free Radic Biol Med; 2001 Apr; 30(8):884-94. PubMed ID: 11295531
[TBL] [Abstract][Full Text] [Related]
9. 4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells.
Cerbone A; Toaldo C; Laurora S; Briatore F; Pizzimenti S; Dianzani MU; Ferretti C; Barrera G
Free Radic Biol Med; 2007 Jun; 42(11):1661-70. PubMed ID: 17462534
[TBL] [Abstract][Full Text] [Related]
10. Lipid peroxidation product 4-hydroxy-2-nonenal acts synergistically with serotonin in inducing vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
Atherosclerosis; 2001 Mar; 155(1):37-44. PubMed ID: 11223424
[TBL] [Abstract][Full Text] [Related]
11. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal.
Ruef J; Rao GN; Li F; Bode C; Patterson C; Bhatnagar A; Runge MS
Circulation; 1998 Mar; 97(11):1071-8. PubMed ID: 9531254
[TBL] [Abstract][Full Text] [Related]
12. Revealing mechanisms of selective, concentration-dependent potentials of 4-hydroxy-2-nonenal to induce apoptosis in cancer cells through inactivation of membrane-associated catalase.
Bauer G; Zarkovic N
Free Radic Biol Med; 2015 Apr; 81():128-44. PubMed ID: 25619142
[TBL] [Abstract][Full Text] [Related]
13. Effects of mGST A4 transfection on 4-hydroxynonenal-mediated apoptosis and differentiation of K562 human erythroleukemia cells.
Cheng JZ; Singhal SS; Saini M; Singhal J; Piper JT; Van Kuijk FJ; Zimniak P; Awasthi YC; Awasthi S
Arch Biochem Biophys; 1999 Dec; 372(1):29-36. PubMed ID: 10562413
[TBL] [Abstract][Full Text] [Related]
14. The effects of angiotensin II and the oxidative stress mediator 4-hydroxynonenal on human osteoblast-like cell growth: possible relevance to otosclerosis.
Rudić M; Milković L; Žarković K; Borović-Šunjić S; Sterkers O; Waeg G; Ferrary E; Bozorg Grayeli A; Žarković N
Free Radic Biol Med; 2013 Apr; 57():22-8. PubMed ID: 23261942
[TBL] [Abstract][Full Text] [Related]
15. The carcinostatic and proapoptotic potential of 4-hydroxynonenal in HeLa cells is associated with its conjugation to cellular proteins.
Sovic A; Borovic S; Loncaric I; Kreuzer T; Zarkovic K; Vukovic T; Wäg G; Hrascan R; Wintersteiger R; Klinger R; Zurak N; Schaub RJ; Zarkovic N
Anticancer Res; 2001; 21(3B):1997-2004. PubMed ID: 11497289
[TBL] [Abstract][Full Text] [Related]
16. Effect of 4-hydroxynonenal on antioxidant capacity and apoptosis induction in Jurkat T cells.
Larini A; Bianchi L; Bocci V
Free Radic Res; 2004 May; 38(5):509-16. PubMed ID: 15293559
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
18. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
Haydon RC; Zhou L; Feng T; Breyer B; Cheng H; Jiang W; Ishikawa A; Peabody T; Montag A; Simon MA; He TC
Clin Cancer Res; 2002 May; 8(5):1288-94. PubMed ID: 12006550
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic and cytostatic effects induced by 4-hydroxynonenal in human osteosarcoma cells.
Calonghi N; Boga C; Cappadone C; Pagnotta E; Bertucci C; Fiori J; Masotti L
Biochem Biophys Res Commun; 2002 May; 293(5):1502-7. PubMed ID: 12054686
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition and differentiation induction in murine erythroleukemia cells by 4-hydroxynonenal.
Rinaldi M; Barrera G; Spinsanti P; Pizzimenti S; Ciafrè SA; Parella P; Farace MG; Signori E; Dianzani MU; Fazio VM
Free Radic Res; 2001 Jun; 34(6):629-37. PubMed ID: 11697038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
